These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 2522920
1. Ro 03-8799: preferential relative uptake in human tumor xenografts compared to a murine tumor: comparison with SR-2508. Lespinasse F, Thomas C, Bonnay M, Malaise EP, Guichard M. Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1105-9. PubMed ID: 2522920 [Abstract] [Full Text] [Related]
2. Radiosensitization by the combination of etanidazole (SR-2508) and pimonidazole (Ro 03-8799) in human tumor xenografts. Taghian A, Lespinasse F, Guichard ME. Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1535-40. PubMed ID: 1834621 [Abstract] [Full Text] [Related]
3. Relationship between intracellular concentration and radiosensitizing effect of pimonidazole and etanidazole on two human melanoma cell lines. el Gamoussi R, Stratford IJ, Guichard M. Int J Radiat Biol; 1993 Jan; 63(1):27-36. PubMed ID: 8093465 [Abstract] [Full Text] [Related]
4. Radiosensitizing effects of misonidazole and SR 2508 on a human melanoma transplanted in nude mice: influence on repair of potentially lethal damage. Guichard M, Malaise EP. Int J Radiat Oncol Biol Phys; 1982 Jan; 8(3-4):465-8. PubMed ID: 6213589 [Abstract] [Full Text] [Related]
5. Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole). Newman HF, Bleehen NM, Ward R, Workman P. Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):677-84. PubMed ID: 2843488 [Abstract] [Full Text] [Related]
6. Additivity of radiosensitization by the combination of SR 2508 (etanidazole) and Ro 03-8799 (pimonidazole) in a murine tumor system. Honess DJ, Wasserman TH, Workman P, Ward R, Bleehen NM. Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):671-5. PubMed ID: 2971028 [Abstract] [Full Text] [Related]
8. Uptake and additivity of the radiosensitizing effects of Ro 03-8799 and SR-2508 in mammalian cells in vitro. Watts ME, Dennis MF, Woodcock M. Br J Radiol; 1987 Dec; 60(720):1233-5. PubMed ID: 2961396 [No Abstract] [Full Text] [Related]
10. The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole). Newman HF, Ward R, Workman P, Bleehen NM. Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1073-83. PubMed ID: 2972667 [Abstract] [Full Text] [Related]
11. Abnormal clinical pharmacokinetics of the developmental radiosensitizers pimonidazole (Ro 03-8799) and etanidazole (SR 2508). Maughan TS, Newman HF, Bleehen NM, Ward R, Workman P. Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1151-6. PubMed ID: 2140825 [Abstract] [Full Text] [Related]
12. A comparison of radiosensitization by etanidazole and pimonidazole in mouse tumors. Stone HB, Hirst VK, Cribbs R, Luu YH, Brown JM. Int J Radiat Oncol Biol Phys; 1991 May; 20(5):987-95. PubMed ID: 1827089 [Abstract] [Full Text] [Related]
14. A multiple dose study of the combined radiosensitizers Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole). Bleehen NM, Newman HF, Maughan TS, Workman P. Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1093-6. PubMed ID: 2539346 [Abstract] [Full Text] [Related]
16. Radiosensitization by 2-nitroimidazole nucleoside analog RP-170: radiosensitizing effects under both intravenous and oral administration. Murayama C, Suzuki A, Sato C, Tanabe Y, Miyata Y, Shoji T, Suzuki T, Sakaguchi M, Mori T. Int J Radiat Oncol Biol Phys; 1992 Apr; 22(3):557-60. PubMed ID: 1531214 [Abstract] [Full Text] [Related]
17. Pharmacokinetics of Ro 03-8799 in mice bearing melanosarcoma: comparison with tumors without melanin. Laurent F, Canal P, Soula G. Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1101-3. PubMed ID: 2703390 [Abstract] [Full Text] [Related]